Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison (CROSBI ID 82399)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Škalko, Nataša ; Brandl, Martin ; Bećirević-Laćan, Mira ; Filipović-Grčić, Jelena ; Jalšenjak, Ivan Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison // European journal of pharmaceutical sciences, 4 (1996), 359-366-x

Podaci o odgovornosti

Škalko, Nataša ; Brandl, Martin ; Bećirević-Laćan, Mira ; Filipović-Grčić, Jelena ; Jalšenjak, Ivan

engleski

Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison

Inclusion complexes of nifedipine with 2-hydroxypropyl-beta.cyclodextrin (HPbetaCD) were formed by the spray- and freeze-drying methods. Nifedipineor its inclusion complexes (Nifedipine-CD complex I and II) were incorporated into liposomes prepared by the ethanol injection method. The highest entrapment value (77.7%) of the starting material) was achieved for liposomes with N-CD complex II. The interaction of nifedipine with lipid bilayers was measured calorimetrically.DPPC liposomes mixed with nifedipine or N-CD complex II showed a slight shift of the transition temperature of DPPC towards lower temperatures compared to DPPC liposomes alone or mixed with HPbetaCD. Encapsulation of drug-cyclodextrin complexes into liposomes can increase the entrapment of the lipophilic drug and reduce its release from the carrier.

liposomes; nifedipine; nifedipine-cyclodextrin; inclusion complex; DSC

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

4

1996.

359-366-x

objavljeno

0928-0987

Povezanost rada

Farmacija

Indeksiranost